Alias
科研级 Pagibaximab ( 帕昔单抗 ), Anti-Lipoteichoic Acid Recombinant Antibody, Research Grade Pagibaximab
Molecular Name
Pagibaximab
Applications
FuncS, IF, Neut, ELISA, FC, IP
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
Staphylococcus epidermidis lipoteichoic acid[Staphylococcus epidermidis]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. As of March 2010, it is undergoing Phase II/III clinical trials.
Storage
该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。